Abstract
(J Clin Anesth. 2022;81:110874) Severe postpartum hemorrhage (PPH) is a leading cause of maternal mortality globally. While fibrinogen concentrate (FC) has been shown to mitigate blood loss in parturients, there is limited evidence on fibrinogen concentrate’s impact on maternal outcomes in the setting of severe PPH. This study aimed to identify the association between FC administration and maternal outcomes in patients with severe PPH requiring red blood cell (RBC) transfusion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
